Style | Citing Format |
---|---|
MLA | Hassanizadeh S, et al.. "Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems." Curcumin-Based Nanomedicines as Cancer Therapeutics, vol. , no. , 2024, pp. 431-442. |
APA | Hassanizadeh S, Askari G, Kesharwani P, Bagherniya M, Sahebkar A (2024). Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems. Curcumin-Based Nanomedicines as Cancer Therapeutics, (), 431-442. |
Chicago | Hassanizadeh S, Askari G, Kesharwani P, Bagherniya M, Sahebkar A. "Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems." Curcumin-Based Nanomedicines as Cancer Therapeutics , no. (2024): 431-442. |
Harvard | Hassanizadeh S et al. (2024) 'Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems', Curcumin-Based Nanomedicines as Cancer Therapeutics, (), pp. 431-442. |
Vancouver | Hassanizadeh S, Askari G, Kesharwani P, Bagherniya M, Sahebkar A. Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems. Curcumin-Based Nanomedicines as Cancer Therapeutics. 2024;():431-442. |
BibTex | @article{ author = {Hassanizadeh S and Askari G and Kesharwani P and Bagherniya M and Sahebkar A}, title = {Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems}, journal = {Curcumin-Based Nanomedicines as Cancer Therapeutics}, volume = {}, number = {}, pages = {431-442}, year = {2024} } |
RIS | TY - JOUR AU - Hassanizadeh S AU - Askari G AU - Kesharwani P AU - Bagherniya M AU - Sahebkar A TI - Clinical Trials, Patents, and Marketed Products of Nanocurcumin-Based Anticancer Drug Delivery Systems JO - Curcumin-Based Nanomedicines as Cancer Therapeutics VL - IS - SP - 431 EP - 442 PY - 2024 ER - |